Kenvue Inc (KVUE) Stock Price, Quote & News

Company Profile

Kenvue Inc. operates as a consumer health company in the United States, rest of North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. It operates in three segments: Self Care, Skin Health and Beauty, and Essential Health. The company offers over-the-counter medicine for cough, cold and allergy, pain care, digestive health, smoking cessation, and eye care, as well as other naturally inspired and self-care products, digital diagnostics, and telemedicine; face and bod...

Industry: Household & Personal Products

Sector: Consumer Defensive

Phone: 908 874 1200

Website: www.kenvue.com

Address:

1 Kenvue Way, Summit, United States

MaryCincotta135 Aug. 25 at 6:09 AM

$P $FMX $KVUE $CCL $KMB Pandora benefits from digital audio engagement and advertising, FEMSA benefits from consumer and beverage demand, Kenvue remains focused on consumer-health brands, Carnival benefits from resilient cruise demand, and Kimberly-Clark benefits from staple-product demand and pricing. I'm watching ad growth, Latin American consumption, healthcare brands, cruise bookings, and input costs.

0 · Reply

USAEquityResearch Aug. 25 at 4:34 AM

$KVUE 📊 USAEquityResearch ▲ 19.43 (+1.94%) Trend: Bullish 📈 RSI (14): 51.8 — neutral territory MACD: bearish, below signal line Volume: below average 📌 Key Levels Resistance: 19.57 | Support: 18.79 20-MA: 19.10 | 50-MA: 18.88 💼 Fundamentals Mkt Cap: $37.32B P/E (TTM): 22.3 | Fwd P/E: 15.6 FCF: $1.91B (0.99/sh) Total Debt: $8.61B D/E: 81.62 📉 Options (exp 2026-08-28) ATM IV: 0.8% | Skew: +0.0% (balanced) Max Pain: 5.00 Educational content only. Not financial advice. Full data, options chain & financials: https://usaequityresearch.com/stocks/KVUE

0 · Reply

USAEquityResearch Aug. 22 at 5:44 AM

$KVUE 📊 USAEquityResearch ▲ 19.06 (+0.69%) Trend: Cautiously bearish ↘️ RSI (14): 54.6 — neutral territory MACD: bearish, below signal line Volume: below average 📌 Key Levels Resistance: 19.57 | Support: 18.79 20-MA: 19.09 | 50-MA: 18.85 💼 Fundamentals Mkt Cap: $36.61B P/E (TTM): 22.2 | Fwd P/E: 15.4 FCF: $1.91B (0.99/sh) Total Debt: $8.61B D/E: 81.62 📉 Options (exp 2026-08-28) ATM IV: 29.4% | Skew: +19.1% (put-heavy) P/C Ratio: 0.54 🐂 Bullish lean Max Pain: 19.00 Call wall: 19.50 | Put wall: 19.00 Educational content only. Not financial advice.

0 · Reply

CapitalMonk Aug. 20 at 1:15 AM

$KVUE Price: $19.13 (+1.76%) Trend: Bullish Market Bias (7D): Bearish Bias 📉 Expected Range: ±0.37% RSI: 50.6 | Momentum: Moderate Volume: +15.9% vs avg Volatility: 1.47% Support: $18.48 | Resistance: $19.83 Data and analytics sourced from Thescanner educational research https://www.thescanner.ai

0 · Reply

heikoscreens Aug. 19 at 6:57 PM

Congress filings just updated on my House Trades scanner: Rep. Kevin Hern disclosed sells in $CMCSA, $EL, $KVUE, $MDLZ — all around 8,000 USD, all dated Aug 5, reported this week (that reporting lag is normal, nothing shady). Small size, but four names sold same day is a pattern. Anyone track these filings regularly?

0 · Reply

TragicRain Aug. 19 at 5:22 PM

$KVUE Essity Strikes Agreement To Acquire Kenvue's Feminine Care Operations In Brazil For $284M

0 · Reply

USAEquityResearch Aug. 19 at 10:44 AM

$KVUE 📊 USAEquityResearch ▲ 18.80 (+0.05%) Trend: Cautiously bearish ↘️ RSI (14): 36.9 — weak momentum, approaching oversold MACD: bearish, below signal line Volume: above average 📌 Key Levels Resistance: 19.57 Support: 18.69 20-MA: 19.06 | 50-MA: 18.74 Educational content only. Not financial advice.

0 · Reply

ValuationPolice91 Aug. 17 at 10:25 PM

$KVUE this brand owns Neutrogena. Which dropped Hayden P for suffering with depression $SPY

0 · Reply

Spotterus Aug. 13 at 7:14 PM

$KVUE have a 1000 kvue shares at 15.98. I have no interest in kmb, so if the merger hits i get $3500 and 146 kmb shares. For me it looks better to sell kvue above $19.50 and not dealing with the merger and having to sell 146 kmb shares for ???. again i have zero interest in kmb.

0 · Reply